PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1-(2-hydroxyethyl)pyrrolidin-2-one | 222-359-4 | 3445-11-2 | - | - | 2 | - | - | - | - | - | - | Details |
|
1-(2-hydroxyethyl)-1H-pyrazol-4,5-diyldiammoniumsulfate
PYRAZOL P5; PYRAZOLE DHE
|
429-300-3 | 155601-30-2 | - | - | 1 | - | - | - | - | - | - | Details |
| 1-(2-hydroxy-5-nonyl(branched)-phenyl)ethanone oxime | 627-083-1 | 244235-47-0 | 1 | 1 | 2 | - | 1 | - | - | - | - | Details |
|
1-(2-hydroxy-5-methylphenyl)dodecan-1-one oxime
LAUROPHENON-OXIM; LPO
|
433-200-5 | 50652-76-1 | - | - | - | - | 1 | - | - | - | - | Details |
| 1-(2-Ethylbutyl)cyclohexanecarbonitrile | 619-573-9 | 855425-38-6 | - | - | - | - | 1 | - | - | - | - | Details |
| 1-(2-carboxylatoethyl)-2-(heptadec-8-enyl)-4,5-dihydro-1-(2-hydroxyethyl)-1H-imidazolium | 267-569-7 | 67892-37-9 | - | - | - | - | 1 | - | - | - | - | Details |
| 1-(2-butoxy-1-methylethoxy)propan-2-ol | 249-951-5 | 29911-28-2 | - | - | 1 | - | - | - | - | - | - | Details |
| 1-(2,6-xylyl)thiourea | 229-005-8 | 6396-76-5 | - | - | - | - | 1 | - | - | - | - | Details |
|
1-(2,6-bis(4-tolyl)-1,3-dioxano(5,4-d)-1,3-dioxan-4-yl)ethane-1,2-diol
CLEARLITE NU 005; DISORBENE M; GENISET MD; GLC NU 005; MILLAD 3940; NU 005
|
402-950-5 | 81541-12-0 | - | - | 1 | - | - | - | - | - | - | Details |
| 1-(2,6,6-trimethyl-3-cyclohexen-1-yl)-2-buten-1-one | 260-709-8 | 57378-68-4 | - | - | - | - | 1 | - | - | - | - | Details |